↓ Skip to main content

Breast Cancer Metastasis and Drug Resistance

Overview of attention for book
Cover of 'Breast Cancer Metastasis and Drug Resistance'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Breast Cancer Statistics: Recent Trends
  3. Altmetric Badge
    Chapter 2 Epidemiology of Breast Cancer in Women
  4. Altmetric Badge
    Chapter 3 Health and Racial Disparity in Breast Cancer
  5. Altmetric Badge
    Chapter 4 Breast Cancer: Current Perspectives on the Disease Status
  6. Altmetric Badge
    Chapter 5 Role of Autophagy in Breast Cancer Development and Progression: Opposite Sides of the Same Coin
  7. Altmetric Badge
    Chapter 6 Breast Cancer Heterogeneity in Primary and Metastatic Disease
  8. Altmetric Badge
    Chapter 7 Bone Metastasis of Breast Cancer
  9. Altmetric Badge
    Chapter 8 Therapeutic Options for Metastatic Breast Cancer
  10. Altmetric Badge
    Chapter 9 Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment
  11. Altmetric Badge
    Chapter 10 Current Updates on Trastuzumab Resistance in HER2 Overexpressing Breast Cancers
  12. Altmetric Badge
    Chapter 11 Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers
  13. Altmetric Badge
    Chapter 12 TRAIL Mediated Signaling in Breast Cancer: Awakening Guardian Angel to Induce Apoptosis and Overcome Drug Resistance
  14. Altmetric Badge
    Chapter 13 Current State of Platinum Complexes for the Treatment of Advanced and Drug-Resistant Breast Cancers
  15. Altmetric Badge
    Chapter 14 Targeting of JAK-STAT Signaling in Breast Cancer: Therapeutic Strategies to Overcome Drug Resistance
  16. Altmetric Badge
    Chapter 15 Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance
  17. Altmetric Badge
    Chapter 16 Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals
  18. Altmetric Badge
    Chapter 17 Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC
  19. Altmetric Badge
    Chapter 18 Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability
  20. Altmetric Badge
    Chapter 19 NEDD4 Family of E3 Ubiquitin Ligases in Breast Cancer: Spotlight on SMURFs, WWPs and NEDD4
  21. Altmetric Badge
    Chapter 20 Emerging Novel Therapeutics in Triple-Negative Breast Cancer
  22. Altmetric Badge
    Chapter 21 Breast Cancer: Proteolysis and Migration
  23. Altmetric Badge
    Chapter 22 Current and Emerging 3D Models to Study Breast Cancer
Attention for Chapter 3: Health and Racial Disparity in Breast Cancer
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 5,278)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
73 news outlets
policy
1 policy source
twitter
6 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
495 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Health and Racial Disparity in Breast Cancer
Chapter number 3
Book title
Breast Cancer Metastasis and Drug Resistance
Published in
Advances in experimental medicine and biology, August 2019
DOI 10.1007/978-3-030-20301-6_3
Pubmed ID
Book ISBNs
978-3-03-020300-9, 978-3-03-020301-6
Authors

Clement G. Yedjou, Jennifer N. Sims, Lucio Miele, Felicite Noubissi, Leroy Lowe, Duber D. Fonseca, Richard A. Alo, Marinelle Payton, Paul B. Tchounwou, Yedjou, Clement G., Sims, Jennifer N., Miele, Lucio, Noubissi, Felicite, Lowe, Leroy, Fonseca, Duber D., Alo, Richard A., Payton, Marinelle, Tchounwou, Paul B.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 495 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 495 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 10%
Student > Bachelor 48 10%
Student > Ph. D. Student 35 7%
Researcher 32 6%
Student > Doctoral Student 27 5%
Other 56 11%
Unknown 249 50%
Readers by discipline Count As %
Medicine and Dentistry 66 13%
Biochemistry, Genetics and Molecular Biology 48 10%
Nursing and Health Professions 31 6%
Engineering 16 3%
Pharmacology, Toxicology and Pharmaceutical Science 14 3%
Other 59 12%
Unknown 261 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 570. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2024.
All research outputs
#42,404
of 25,818,700 outputs
Outputs from Advances in experimental medicine and biology
#3
of 5,278 outputs
Outputs of similar age
#825
of 351,120 outputs
Outputs of similar age from Advances in experimental medicine and biology
#1
of 63 outputs
Altmetric has tracked 25,818,700 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,278 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,120 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.